Clinical characteristics of metastatic tumors to the ovaries

Journal of Korean Medical Science

Volumn 24, Issue 1, 2009, Pages 114-119

  Lee, Sung Jong ^a   Bae, Jeong Hoon ^a   Lee, A Won ^a   Tong, Seo Yun ^a   Park, Yong Gyu ^b   Park, Jong Sup ^a  

^a The Catholic University of Korea   (South Korea)

^b Kyung Hee University College of Medicine   (South Korea)

Author keywords

Diagnostic imaging; Metastasis; Ovary; Prevalence; Surgical procedures

Indexed keywords

CA 125 ANTIGEN;

ADENOCARCINOMA; ADULT; ARTICLE; BLOOD; DIFFERENTIAL DIAGNOSIS; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; MEDICAL RECORD; METASTASIS; MIDDLE AGED; OVARIECTOMY; OVARY TUMOR; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL;

ADENOCARCINOMA; ADULT; CA-125 ANTIGEN; DATA INTERPRETATION, STATISTICAL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; MEDICAL RECORDS; MIDDLE AGED; OVARIAN NEOPLASMS; OVARIECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 65649118863     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2009.24.1.114     Document Type: Article

References (22)

1. Young RH, Scully RE. Metastatic tumors of the ovary. In: Kurman RJ, eds. Blaustein's pathology of the female genital tract. 5th ed. New York: Springer 2002; 1063-101.
2. McCluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathology 2005; 47: 231-47.
3. Yada-Hashimoto N, Yamamoto T, Kamiura S, Seino H, Ohira H, Sawai K, Kimura T, Saji F. Metastatic ovarian tumors: a review of 64 cases. Gynecol Oncol 2003; 89: 314-7.
4. Moore RG, Chung M, Granai CO, Gajewski W, Steinhoff MM. Incidence of metastasis to the ovaries from nongenital tract primary tumors. Gynecol Oncol 2004; 93: 87-91.
5. Ayhan A, Guvenal T, Salman MC, Ozyuncu O, Sakinci M, Basaran M. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 2005; 98: 235-41.
6. Khunamornpong S, Suprasert P, Chiangmai WN, Siriaunkgul S. Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand. Int J Gynecol Cancer 2006; 16 (Suppl 1): 132-8.
7. Antila R, Jalkanen J, Heikinheimo O. Comparison of secondary and primary ovarian malignancies reveals differences in their pre- and perioperative characteristics. Gynecol Oncol 2006; 101: 97-101.
8. Brown DL, Zou KH, Tempany CM, Frates MC, Silverman SG, McNeil BJ, Kurtz AB. Primary versus secondary ovarian malignancy: imaging findings of adnexal masses in the Radiology Diagnostic Oncology Group study. Radiology 2001; 219: 213-8.
9. Alcázar JL, Galán MJ, Ceamanos C, Garćia-Manero M. Transvaginal gray scale and color Doppler sonography in primary ovarian cancer and metastatic ovarian tumors to the ovary. J Ultrasound Med 2003; 22: 243-7.
10. Choi HJ, Lee JH, Seo SS, Lee S, Kim SK, Kim JY, Lee JS, Park SY, Kim YH. Computed tomography findings of ovarian metastases from colon cancer: comparison with primary malignant ovarian tumors. J Comput Assist Tomogr 2005; 29: 69-73.
11. Koyama T, Mikami Y, Saga T, Tamai K, Togashi K. Secondary ovarian tumors: spectrum of CT and MR features with pathologic correlation. Abdom Imaging 2007; 32: 784-95.
12. Kim HK, Heo DS, Bang YJ, Kim NK. Prognostic factors of Krukenberg's tumor. Gynecol Oncol 2001; 82: 105-9.
13. Kikkawa F, Ino K, Nomura S, Ishikawa H, Kuzuya K, Yamamuro O, Kobayashi I, Kawai M, Mizutani S. Prognostic factors of secondary ovarian carcinoma. Oncology 2002; 63: 124-9.
14. Eitan R, Gemignani ML, Venkatraman ES, Barakat RR, Abu-Rustum NR. Breast cancer metastatic to abdomen and pelvis: role of surgical resection. Gynecol Oncol 2003; 90: 397-401.
15. Cheong JH, Hyung WJ, Chen J, Kim J, Choi SH, Noh SH. Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer. Gynecol Oncol 2004; 94: 477-82.
16. Tserkezoglou A, Kontou S, Hadjieleftheriou G, Apostolikas N, Vassilomanolakis M, Sikiotis K, Salamalekis E, Tseke P, Magiakos G. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results. Anticancer Res 2006; 26: 2339-44.
17. Stat bite: Age-specific incidence and mortality rates for ovarian cancer, 1998-2002. J Natl Cancer Inst 2006; 98: 511.
18. Prat J. Ovarian carcinomas, including secondary tumors: diagnostically challenging areas. Mod Pathol 2005; 18: S99-111.
19. Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, Mooney J, Verbeke C, Bellamy C, Keith WN, Oien KA. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res 2005; 11: 3766-72.
20. GLOBOCAN 2002 cancer incidence. Mortality and prevalence worldwide. IARC CancerBase; 2002.
21. Bae JH, Lee JM, Ryu KS, Lee YS, Park YG, Hur SY, Ahn WS, Namkoong SE. Treatment of ovarian cancer with paclitaxel- or carboplatin-based intraperitoneal hyperthermic chemotherapy during secondary surgery. Gynecol Oncol 2007; 106: 193-200.
22. Tong SY, Lee YS, Park JS, Bae SN, Lee JM, Namkoong SE. Clinical analysis of synchronous primary neoplasms of the female reproductive tract. Eur J Obstet Gynecol Reprod Biol 2008; 136: 78-82.